Key result
In patients with CKD, epicardial adipose tissue correlated with coronary artery calcification (Spearman ρ 0.388; 95% CI 0.287–0.532), but this relation was dependent on cardiovascular risk factors.
Why the study?
The independent association between epicardial adipose tissue and cardiovascular calcification in patients with chronic kidney disease remains controversial.
Is epicardial adipose tissue associated with cardiovascular risk factors and calcifications in patients with chronic kidney disease?
Cross-Sectional (n=257)
Is epicardial adipose tissue associated with cardiovascular risk factors and calcifications in patients with chronic kidney disease?
In patients with CKD, epicardial adipose tissue correlates with cardiovascular risk scores and calcifications, though the relationship with calcifications is dependent on traditional cardiovascular risk factors.
Background Epicardial adipose tissue (EAT) exerts cardiopathogenic effects, but the independent association between EAT and cardiovascular (CV) calcification in patients with chronic kidney disease (CKD) remains controversial. We therefore assessed the association between EAT, CV risk factors and CV calcifications. Methods 257 patients with CKD Stage 3 and/or overt proteinuria underwent quantification of EAT, coronary artery calcification and aortic valve calcification by computed tomography. Framingham and American College of Cardiology and American Heart Association (ACC-AHA) 10-year CV event risk scores were calculated for each patient. Results Using multivariable regression analysis, higher EAT was significantly associated with the majority of investigated risk factors {higher age: odds ratio [OR] 1.05/year [95% confidence interval (CI) 1.02–1.08]; male sex: OR 4.03 [95% CI 2.22–7.31]; higher BMI: OR 1.28/kg/m2 [95% CI 1.20–1.37]; former smoking: OR 1.84 [95% CI 1.07–3.17]; lower high-density lipoprotein cholesterol: OR 0.98/mg/dL [95% CI 0.96–1.00] and lower estimated glomerular filtration rate: OR 0.98/mL/min/1.73 m2 [95% CI 0.97–0.99]; all P < 0.05} and was not associated with diabetes mellitus, hypertensive nephropathy, total cholesterol and albuminuria. EAT was positively associated with higher ACC-AHA and Framingham risk scores. EAT correlated with coronary artery calcification and aortic valve calcification [Spearman ρ = 0.388 (95% CI 0.287–0.532) and rrb = 0.409 (95% CI 0.310–0.556), respectively], but these correlations were dependent on CV risk factors. Conclusions The increase of EAT can be explained by individual CV risk factors and kidney function and correlates with 10-year risk for CV event scores, suggesting that EAT is a modifiable risk factor in patients with CKD. Although EAT correlates with CV calcifications, these relations depend on CV risk factors.
No takes yet. Share an insight, caveat, or question.
Saritas et al. (2019) conducted a cross-sectional in Chronic kidney disease (n=257). Epicardial adipose tissue (EAT) was evaluated on Coronary artery calcification (Spearman ρ 0.388, 95% CI 0.287-0.532). In patients with CKD, epicardial adipose tissue correlated with coronary artery calcification (Spearman ρ 0.388; 95% CI 0.287–0.532), but this relation was dependent on cardiovascular risk factors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: